Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Feb 25, 2015
Company News
Shire exercises option to acquire Meritage
...of the deal's milestones as well. Meritage's investors include Domain Associates, Latterell Venture Partners and
the Vertical Group
. BC...
Read More
BioCentury
|
Aug 2, 2013
Politics & Policy
BIO, PhRMA split on special use pathway
...an SMU pathway could scuttle the concept. Jack Lasersohn, a general partner at VC firm
The Vertical Group
...
Read More
BioCentury
|
Oct 13, 2010
Company News
Cell Biosciences to acquire Convergent
...Existing investors Wellcome Trust; Novo A/S; Domain Associates; Latterell Venture Partners; Royal Bank of Canada;
The Vertical Group
...
Read More
BioCentury
|
Sep 14, 2009
Company News
Alpha Innotech, Cell Biosciences deal
...D round. Existing investors The Wellcome Trust ; Domain Associates; Novo A/S; Latterell Venture Partners;
The Vertical Group
...
Read More
BioCentury
|
Apr 10, 2009
Financial News
Cell Biosciences raises $10 million
...investors Domain Associates; Latterell Venture Partners; Novo A/S; Mitsui Ventures; Royal Bank of Canada; and
The Vertical Group
...
Read More
BioCentury
|
Nov 10, 2008
Finance
Ebb & Flow
...Adams Street Partners led the round, with participation from U.S. Venture Partners; Latterell Venture Partners;
The Vertical Group
...
Read More
BioCentury
|
Nov 5, 2008
Top Story
OncoMed raises $93 million
...Partners led the overall B round, with participation from U.S. Venture Partners; Latterell Venture Partners;
The Vertical Group
...
Read More
BioCentury
|
Sep 15, 2008
Finance
Ebb & Flow
...joined existing investors Advanced Technology Ventures; Delphi Ventures; Latterell Venture Partners; U.S. Venture Partners; and
The Vertical Group
...
Read More
BioCentury
|
Sep 9, 2008
Financial News
Proteolix raises $79 million
...and existing investors Advanced Technology Ventures; Delphi Ventures; Latterell Venture Partners; U.S. Venture Partners; and
The Vertical Group
...
Read More
BioCentury
|
Jun 23, 2008
Company News
Verus Pharma inflammation news
...raised $22.5 million in a series A round through Domain Associates; Latterell Venture Partners; and
The Vertical Group
...
Read More
Items per page:
10
1 - 10 of 18
BioCentury
|
Feb 25, 2015
Company News
Shire exercises option to acquire Meritage
...of the deal's milestones as well. Meritage's investors include Domain Associates, Latterell Venture Partners and
the Vertical Group
. BC...
Read More
BioCentury
|
Aug 2, 2013
Politics & Policy
BIO, PhRMA split on special use pathway
...an SMU pathway could scuttle the concept. Jack Lasersohn, a general partner at VC firm
The Vertical Group
...
Read More
BioCentury
|
Oct 13, 2010
Company News
Cell Biosciences to acquire Convergent
...Existing investors Wellcome Trust; Novo A/S; Domain Associates; Latterell Venture Partners; Royal Bank of Canada;
The Vertical Group
...
Read More
BioCentury
|
Sep 14, 2009
Company News
Alpha Innotech, Cell Biosciences deal
...D round. Existing investors The Wellcome Trust ; Domain Associates; Novo A/S; Latterell Venture Partners;
The Vertical Group
...
Read More
BioCentury
|
Apr 10, 2009
Financial News
Cell Biosciences raises $10 million
...investors Domain Associates; Latterell Venture Partners; Novo A/S; Mitsui Ventures; Royal Bank of Canada; and
The Vertical Group
...
Read More
BioCentury
|
Nov 10, 2008
Finance
Ebb & Flow
...Adams Street Partners led the round, with participation from U.S. Venture Partners; Latterell Venture Partners;
The Vertical Group
...
Read More
BioCentury
|
Nov 5, 2008
Top Story
OncoMed raises $93 million
...Partners led the overall B round, with participation from U.S. Venture Partners; Latterell Venture Partners;
The Vertical Group
...
Read More
BioCentury
|
Sep 15, 2008
Finance
Ebb & Flow
...joined existing investors Advanced Technology Ventures; Delphi Ventures; Latterell Venture Partners; U.S. Venture Partners; and
The Vertical Group
...
Read More
BioCentury
|
Sep 9, 2008
Financial News
Proteolix raises $79 million
...and existing investors Advanced Technology Ventures; Delphi Ventures; Latterell Venture Partners; U.S. Venture Partners; and
The Vertical Group
...
Read More
BioCentury
|
Jun 23, 2008
Company News
Verus Pharma inflammation news
...raised $22.5 million in a series A round through Domain Associates; Latterell Venture Partners; and
The Vertical Group
...
Read More
Items per page:
10
1 - 10 of 18
Previous page
Next page